In today's global business context, high competition forces companies to operate in highly uncertain conditions. Whenever these uncertainties convert into risk, and the risk becomes reality the companies may face profitability loss. Moreover, if the company is dealing in the healthcare sector, a loss is not limited to profitability instead, it may lead to the loss of lives. Resilient Healthcare Supply Chain (RHSC) could be an answer to the uncertain disruption challenges. Although various studies have proposed a resilient supply chain, this research paper addresses the partially filled gap for RHSC. This research assumes that all medicinal products supply chain does not require the same level of resilience.

Moreover, it is challenging to achieve resilience free of cost. Hence, this research uses a vulnerability-capability framework to map the resilience requirements as a function of vulnerability and corresponding capability. Furthermore, it uses Total Interpretative Structural Modelling to establish a hierarchical relationship among various factors to better explain the relationships. In addition, this study uses MICMAC analyses which helps classify variables as drivers, linkages, and autonomous and dependent variables. This research concludes with interesting findings about the "what " and "how" of the theory and some future research directions with limitations of this research.